We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.
Loading
-
AI and Digital Health -
Brain Health -
Cardiovascular -
Cell and Gene Therapy and Genome Editing - Contract Manufacturing Organization
- Dermatology
-
Diagnostics and Personalized Medicine - Immunology
-
Infectious Disease and Vaccines - Inflammation
- Medical Devices
- Metabolic Diseases
- Multiline Global Biopharma
- Multiple Therapeutics
-
Oncology - Ophthalmology
-
Orphan and Rare Disease - Other
- Pain Management
- Platform for Therapeutics
- Regenerative Medicine
- Reproductive/Sexual Health
- Respiratory
- Tools/Drug Development Support Tech
-
- Oncology
Theater 3Abdi İbrahim Pharmaceuticals is Turkey’s leading pharmaceutical company with more than 24 years of market leadership, operations in over 70 countries, and approximately USD 1,1 billion in annual reven ... -
- Multiple Therapeutics
Theater 1Commercial company operating in 85 countries around the globe with an extensive R&D portfolio - presently 9 projects -
- Brain Health
Theater 4AgenT is a French company developing blood-based multiomic solutions to transform how neurodegenerative diseases are diagnosed, monitored, and treated. With an initial focus on Alzheimer’s disease, Ag ... -
- AI and Digital Health
Theater 2Alivexis, Inc. is a technology-driven drug discovery company creating small-molecule therapeutics through advanced molecular simulation and AI. Our proprietary ModBind platform enables high-speed, hig ... -
- Dermatology
Theater 1Alphyn is using its Zabalafin Drug Platform to develop unique Multi-Target Therapeutics® to be more efficacious and patient tolerable. The Zabalafin Platform is an impactful innovation because it has ... -
- Diagnostics and Personalized Medicine
Theater 1Altratech’s multidisciplinary team has developed a novel multimodal platform for the detection and quantification of infectious viruses, DNA, RNA, antibodies, and antigens. Incorporating PNA probes (c ... -
- Pain Management
Theater 2AmacaThera is a leading developer of next-generation hydrogel-based drug delivery solutions. Using a proprietary blend of known polymers, AmacaThera's clinically validated hydrogel platform is transfo ... -
- Oncology
Theater 2Amgen is a global biotechnology company focused on discovering, developing, manufacturing, and delivering innovative human therapeutics. Founded in 1980 and headquartered in Thousand Oaks, California, ... -
- Platform for Therapeutics
Theater 1Applied Biotechnology Institute (ABI) has developed a protein production platform to address limitations found in cell culture systems. Conventional methods often require high-cost manufacturing, stri ... -
- Immunology
Theater 3Artiva is a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with debilitating autoimmune diseases. Artiva’s lead program, Al ... -
- Multiple Therapeutics
Theater 3Artivila Biopharma is a leading clinical stage biotechnology company that focuses on empowering innovative drug discovery with an advanced AIDD+CADD drug discovery platform. With years of successful d ... -
- Orphan and Rare Disease
Theater 4Asahi Kasei has built a global presence in the pharmaceutical sector through strategic acquisitions and investments. Since 2020, we have acquired Veloxis, a company specializing in solid organ transpl ... -
- Brain Health
Theater 4AstronauTx’s is targeting sleep architecture as a therapeutic approach to treat neurological disease. Our thesis is that changes in sleep architecture underpin disease and that sleep is a modifiable r ... -
- Oncology
Theater 3atbtherapeutics is a Belgium‑based, preclinical‑stage biotechnology company developing next‑generation targeted therapies. The company engineers novel biologics that integrate differentiated cell‑kill ... -
- Inflammation
Theater 1Atom Therapeutics is privately held clinical stage Chinese biotech company founded in 2012. Atom is developing best-in-class oral small molecule drugs for treatment of inflammatory, metabolic and card ... -
- Metabolic Diseases
Theater 3Atrogi is a Phase II-ready biotechnology company developing oral therapies that preserve and build functional muscle. Our lead compound, ATR-258, delivers healthy weight loss with improved muscle mass ... -
- Respiratory
Theater 4Avanti Biosciences is a San Diego-based biotechnology company developing ABI-171, a first-in-class multi-kinase inhibitor for idiopathic pulmonary fibrosis (IPF). Unlike approved therapies that only s ... -
- Cell and Gene Therapy and Genome Editing
Theater 3AviadoBio is on a mission to relentlessly chase cures by developing and translating groundbreaking science and precision delivery into life-changing medicines across neurodegenerative diseases. Built ... -
- Orphan and Rare Disease
Theater 4Azafaros is a company building a portfolio to become a leader in lysosomal storage disorders with the goal of addressing neurological symptoms. It is a clinical-stage company, founded in 2018 with a d ... -
- Dermatology
Theater 1Azitra is a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology. The Company's lead program, ATR-12, uses an engineered strain of S. epidermid ... -
- Oncology
Theater 2Balto is both a platform and a pipeline biotech focused on the discovery of small molecule inhibitors targeting cooperative stability of protein-protein interactions (PPIs) in protein complexes that d ... -
- Oncology
Theater 2Based in Research Triangle Park, NC, Bantam Pharmaceutical is a clinical-stage company pioneering mitochondrial biology to develop first-in-class small molecule therapeutics for treating aggressive ca ... -
- Oncology
Theater 1Beijing Sungen Biomedical Technology Co., Ltd. is an innovation-driven, clinical-stage biotechnology company founded in 2018, pioneering the development of First-in-Class (FIC) and Best-in-Class (BIC) ... -
- Metabolic Diseases
Theater 3BIOIO predicts which drugs will work in humans before clinical trials, and has used this to create a first-in-class diabetes drug. BIOIO's MOAT (mechanism of action technologies) platform contains two ... -
- Orphan and Rare Disease
Theater 4BioMarin is a leading, global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. Founded in 1997, the San Rafael, California-base ... -
- Brain Health
Theater 4BnH Research is a clinical-stage biotech redefining dementia therapy by restoring cortical synaptic plasticity. Our lead asset, BnH-015B, is the world's first GluN2B-NMDAR Positive Allosteric Modulato ... -
- Multiple Therapeutics
Theater 2Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in research and development, the company focuses on developing innova ... -
- AI and Digital Health
Theater 1BostonGene developed the first omnimodal foundation model for tumor and immune biology, redefining how oncology drugs are discovered, developed, and delivered to patients. Built and validated through ... -
- Orphan and Rare Disease
Theater 4BrainStorm Therapeutics is an AI-powered precision neuroscience startup transforming drug discovery for brain diseases by combining patient iPS cell-derived brain organoids with advanced machine learn ... -
- Oncology
Theater 3BSP Pharmaceuticals is a CDMO, technologically developed to meet needs of groundbreakers and specialized in manufacturing Oncology and Immunotherapy drug, including autoimmune disease, immunotherapy & ... -
- Pain Management
Theater 2BTB Therapeutics is a clinical stage drug development company with BTB-101 (a non-opioid analgesic) for acute post-op pain management in Phase 2, and small molecule-based RNA splicing modifiers for ra ... -
- Other
Theater 1Calico (Calico Life Sciences LLC) is an Alphabet-founded research and development company whose mission is to harness advanced technologies and model systems to increase our understanding of the biolo ... -
- Immunology
Theater 3Canopy is developing first-in-class Antigen-Drug Conjugates (AgDCs) for antibody-mediated autoimmunity. Using disease-defining autoantigens, AgDCs combine both the highly selective clearance of pathog ... -
- Contract Manufacturing Organization
Theater 1Celonic is a “Pure Play” Biologics CDMO, providing development, process optimization, and GMP clinical and commercial manufacturing. We have experience with standard mAbs, Bi-Specifics, and other comp ... -
- Infectious Disease and Vaccines
Theater 4Centivax is a universal immunity company, deploying a proprietary computational immune-engineering platform to create vaccines and therapies that deliver universal protection against entire classes of ... -
- Orphan and Rare Disease
Theater 4Cereno Scientific is pioneering treatments to enhance and extend life. Cereno's innovative pipeline offers first-in-class disease-modifying treatments for rare cardiopulmonary disease. Lead candidate ... -
- Multiple Therapeutics
Theater 2Chugai Pharmaceutical Co., Ltd. is a Japan‑based research‑driven pharmaceutical company and a member of the Roche Group. Chugai is committed to creating innovative medicines that address unmet medical ... -
- Platform for Therapeutics
Theater 1CirCode Biomed is a clinical-stage biotechnology company pioneering the development of circular RNA (circRNA) therapeutics. Leveraging a proprietary circRNA technology platform, CirCode has built an i ... -
- Oncology
Theater 3City of Hope is among America’s largest and most advanced institutions for cancer research and treatment. With a more than 110-year legacy of serving humanity, we are an independent academic instituti ... -
- Respiratory
Theater 4Clarametyx Biosciences is combating the formidable challenge of chronic respiratory diseases through an innovative technology platform targeting the biofilm—a protective layer around bacteria that dri ... -
- Oncology
Theater 3CNCure Co., Ltd. is a South Korea–based biotechnology company developing bacteria‑based cancer immunotherapies and radiotheranostic platforms for precision oncology. Its lead candidate, CNC‑101, is a ... -
- Multiple Therapeutics
Theater 3Combined is developing MOP (Muli-Organ Protection), an mRNA translation-cell selective platform designed to reduce off-target expression and make (mRNA) medicines safer and more effective. Combined Tx ... -
- Regenerative Medicine
Theater 1Consano Bio is a clinical stage Biotech developing a first in class allogenic, platelet and plasma derived biologic for the treatment of chronic lumbosacral radiculopathy. C-1101, the companies first ... -
- Multiple Therapeutics
Theater 3Cullinan Therapeutics, Inc. is a biopharmaceutical company developing potential first- or best-in-class, high-impact therapies for autoimmune diseases and cancer. Cullinan pursues promising therapeuti ... -
- Cardiovascular
Theater 4At Cyclarity Therapeutics, our mission is to develop therapeutics which target the root cause of diseases of aging - the accumulation of toxic biomolecules over time. Our lead drug candidate is UDP-00 ... -
- Cardiovascular
Theater 4CytoHub: Transforming Cardiac Development CytoHub is an AI-driven cardiac biology platform company delivering human-relevant models and predictive insights that de-risk and accelerate cardiac drug and ... -
- Reproductive/Sexual Health
Theater 4Daré Bioscience is a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions. Every innovation Daré advances is bas ... -
- Oncology
Theater 2DigmBio: Next-Generation Small-Molecule Therapeutics * DigmBio: Advancing High-Selectivity & Superior BBB-Penetrating Therapies for Oncology and CNS * Established: April 2020 (Bio-startup) * Mission: ... -
- Tools/Drug Development Support Tech
Theater 3Dillico developed the All-ScaleFlow manufacturing platform, an end-to-end automated continuous production equipment for m/sa/gRNA-LNP therapeutics with related digital tools and services. This solutio ... -
- Oncology
Theater 1Dio-Tree is a biotechnology company developing a first-in-class therapeutic approach for ovarian cancer by targeting the enzyme DIO3 within tumor cells. DIO3 regulates intracellular thyroid hormone ac ... -
- Oncology
Theater 2Duo Oncology - backed by BeOne - is a cancer medicine company developing next-generation chemotherapy for solid tumors. Its lead program, DUO-207, consolidates commonly co-administered cytotoxic agent ... -
- Multiline Global Biopharma
Theater 4Dx&Vx is a public Korean biotech company listed on KOSDAQ (180400). Dx&Vx is one of the most innovative companies with uniquely differentiated pipelines and platforms. Dx&Vx is advancing highly differ ... -
- AI and Digital Health
Theater 2Eigen Bio is a frontier wet AI lab. We integrate biology, AI, and causal inference to build a platform that reads gene regulation directly from blood and predicts how it changes under therapeutic inte ... -
- Multiple Therapeutics
Theater 1Elanco is a US based veterinary pharmaceutical company, developing products for both Pet Health and Livestock applications, including therapeutics for chronic disease, anti-microbials, and vaccines. -
- Multiple Therapeutics
Theater 3Eleva is a clinical-stage biopharmaceutical company discovering and developing previously inaccessible biological therapeutics. Eleva’s disruptive moss-based technology platform enables GMP-scale manu ... -
- Multiple Therapeutics
Theater 2Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines ... -
- Cell and Gene Therapy and Genome Editing
Theater 3Elisigen (formerly Neuracle Genetics) is a clinical-stage biotechnology company focused on developing innovative AAV gene therapies to address critical unmet needs in retinal and neurological diseases ... -
- Immunology
Theater 3Elixiron Immunotherapeutics is a clinical-stage biotechnology company listed on the Taipei Emerging Stock Board (7871.TWO), developing differentiated immune-modulating therapies. The company is advanc ... -
- Orphan and Rare Disease
Theater 4Everfront Biotech is a clinical-stage company developing innovative therapies for diseases with high unmet medical need, with an initial focus on glioblastoma and pancreatic cancer. The Company’s plat ... -
- AI and Digital Health
Theater 1Evogene Ltd. (Nasdaq/TASE: EVGN) is focused on improving the probability of success in small-molecule drug discovery. Through ChemPass AI™ (developed in collaboration with Google Cloud), our proprieta ... -
- Platform for Therapeutics
Theater 1ExpressionEdits is a University of Cambridge spin-out advancing biotechnology by enabling it to “speak” nature’s genetic language. Founded by Dr Kärt Tomberg and Professor Allan Bradley, the company h ... -
- Medical Devices
Theater 1Floreo is the leading virtual reality & AI therapy platform for the neurodiverse, those with conditions like autism and ADHD. Floreo's VR therapy solution is currently used by over 80 autism therapy c ... -
- Contract Manufacturing Organization
Theater 1Forge Biologics, a member of Ajinomoto Bio-Pharma Services, is a gene therapy contract development and manufacturing organization (CDMO) enabling access to life-changing gene therapies by bringing the ... -
- Oncology
Theater 2FoRx Therapeutics is a clinical-stage company that develops next-generation small molecule therapeutics targeting DNA Replication Stress pathways for anti-cancer therapy. The lead program is a highly ... -
- Infectious Disease and Vaccines
Theater 4GELITA is one of the leading companies for manufacturing and marketing collagen proteins. Coordinated from headquarters in Eberbach, Germany, GELITA provides customers around the world with products o ... -
- Multiple Therapeutics
Theater 2Founded 50 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical condi ... -
- Regenerative Medicine
Theater 1Genera Research Ltd. is a clinical-stage biotechnology company based in Croatia, and the country's first biotech, pioneering regenerative medicine through recombinant human Bone Morphogenetic Protein ... -
- Cell and Gene Therapy and Genome Editing
Theater 3GeneVentiv Therapeutics is a pre-clinical gene therapy company focused on identifying, in-licensing and developing transformative gene therapies. GeneVentiv has two first-in-class gene therapies for p ... -
- Oncology
Theater 1GI Innovation is a South Korean biotech company founded in 2017 with the mission to improve human health by developing innovative biologics. Publicly listed since 2023, GI Innovation employs 90 staff ... -
- Oncology
Theater 2Gliomic is focused on providing new therapeutic options for large unmet needs in genetically-defined brain tumors. Our scientific founders, including Sam McBrayer PhD (UT Southwestern) and Bill Kaelin ... -
- Oncology
Theater 3We are a clinical-stage biopharmaceutical company focused on our Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 ... -
- Oncology
Theater 1Halia Therapeutics is a clinical-stage biotech developing first-in-class therapies for inflammasome-driven diseases via the NEK7–NLRP3 pathway. Its lead program, ofirnoflast (HT-6184), is in developme ... -
- Oncology
Theater 2Hiba Therapeutics is a Cambridge, MA-based clinical-stage immunotherapy company developing TROIKA, a first-in-class AND-gated antibody-peptide conjugate (APC) platform for solid tumors. Current checkp ... -
- Dermatology
Theater 1Highlight Therapeutics is a privately held biotech at a value inflection point. With Phase 2b data imminent, our validated dsRNA platform and lead asset BO-112 are poised to deliver the first broadly ... -
- Multiple Therapeutics
Theater 4A clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform. -
- Platform for Therapeutics
Theater 1ILIAS Biologics is a clinical-stage biotechnology company developing engineered exosome therapeutics for targeted intracellular delivery. Leveraging its proprietary EXPLOR® platform, ILIAS enables eff ... -
- Immunology
Theater 3ImageneBio is a clinical-stage biotechnology company developing therapeutics for patients who have immunological, autoimmune and inflammatory diseases. IMG-007 is our next-generation investigational a ... -
- Immunology
Theater 3ImmuneOnco is a publicly traded, clinical-stage biotechnology company focused on discovering and developing therapies for cancer, autoimmune, cardiovascular, and metabolic diseases. Our wholly owned p ... -
- Regenerative Medicine
Theater 1Immunis is a clinical-stage biotech developing a first-in-class stem cell-derived secretome product targeting the underlying factors of aging biology that drive immune-mediated muscle and metabolic di ... -
- Infectious Disease and Vaccines
Theater 4Immuno Cure Holding (HK) Limited ("Immuno Cure") is a Hong Kong-based biotechnology company pioneering DNA medicine and antibody platforms for infectious diseases and cancers. Our "PD-1-Enhanced DNA M ... -
- Oncology
Theater 3ImmunoMet Therapeutics is a clinical stage biotech targeting cellular metabolism to advance novel anti-cancer therapies. Our lead molecule, lixumistat (IM156), is an orally bioavailable small molecule ... -
- Immunology
Theater 3Inimmune is made up of a team of innate immunodulation experts developing next generation immunotherapies the treatment of allergy and inflammation. -
- Multiple Therapeutics
Theater 3Innogen Pharmaceuticals is a HKex listed biopharma company based in China. Our leading asset, Efsubaglutide α, is with an half-life of 280 hours, enabling a once-MONTHLY dosing for weight management a ... -
- Multiple Therapeutics
Theater 1InstaPill® is a globally recognized CDMO specializing in orally disintegrating tablets using our proprietary InstaPill® technology platform. Our facility in Bengaluru, India, houses experienced pharma ... -
- Oncology
Theater 3InterAct Therapeutics is a biotech startup developing precision therapies to treat metastatic cancers by targeting the unique biology of organ-specific disease. Its lead program, IAT-S2, is designed f ... -
- Regenerative Medicine
Theater 1JangoBio is a regenerative medicine company developing stem cell–based therapies to treat diseases of aging and extend healthy longevity. Its pipeline is led by Jango-Renew, an advanced stem cell ther ... -
- Medical Devices
Theater 3JHK Medical Science Inc. is a company specializing in the early detection of Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI). Founded in 2020 by CEO Seo Yun Jo (MD, Ph.D.), the company is ... -
- Reproductive/Sexual Health
Theater 4Kadence Bio (kadencebio.com) is developing the first FDA-approved treatment for premature ejaculation (PE). Aim is to close the “intimacy gap,” roughly a 3x difference in time to climax between health ... -
- Oncology
Theater 3Kazia Therapeutics is a clinical-stage oncology company focused on high-need cancers of the central nervous system and select aggressive solid tumors. Our mission is to redefine cancer treatment by mo ... -
- Cell and Gene Therapy and Genome Editing
Theater 3Kernal Bio is a VC-backed biotech company pioneering in vivo CAR-T therapies. We harness selective mRNA-LNP technology to treat cancer and autoimmune diseases with precision—ensuring targeted delivery ... -
- Diagnostics and Personalized Medicine
Theater 1Kihealth is building a next-generation diagnostics platform that detects disease at the cellular level, years before symptoms or standard biomarkers emerge. The company’s proprietary liquid biopsy tec ... -
- Multiline Global Biopharma
Theater 1King Abdullah International Medical Research Center (KAIMRC) is a leading biomedical research institution in Saudi Arabia dedicated to advancing scientific discovery and improving public health throug ... -
- Other
Theater 1King Saud bin Abdulaziz University for Health Sciences (KSAU-HS) is a leading academic health institution in Saudi Arabia dedicated to advancing medical education, research, and innovation. As part of ... -
- Multiple Therapeutics
Theater 1Knoa Pharma is a public health–focused pharmaceutical company dedicated to developing innovative, small molecule therapeutics that address significant unmet medical needs. We also seek to expand acces ... -
- Diagnostics and Personalized Medicine
Theater 1Ever since the first anticancer drugs were discovered combination therapies were in the focus of attention because very few single drugs carry the potential to fundamentally change the trajectory of c ... -
- Cell and Gene Therapy and Genome Editing
Theater 3Lexeo Therapeutics is a New York City-based, clinical-stage genetic medicine company dedicated to reshaping heart health by applying pioneering science to fundamentally change how cardiovascular disea ... -
- Immunology
Theater 3LIfT BioSciences is pioneering a new class of immunotherapy for hard-to-treat cancers based on allogeneic Immuno Modulatory Alpha Neutrophils (IMANs)®. Our proprietary, long-lived IMANs harness neutro ... -
- Infectious Disease and Vaccines
Theater 4LIV Process is the first and only product in the world to provide microbial visualization of C. diff spores, the longest-living and one of the most dangerous pathogens in the world. LIV Process is a t ... -
- Orphan and Rare Disease
Theater 4Longeveron is a clinical-stage company developing Laromestrocel, an allogenic "off-the-shelf" bone marrow-derived mesenchymal stem cell therapy for rare pediatric diseases and chronic aging-related co ... -
- Brain Health
Theater 4Loop Bio is a Biohaven Pharmaceuticals spinout developing a novel pharmacotherapy for obsessive-compulsive disorder (OCD), Tourette Syndrome (TS), and related neuropsychiatric conditions. Our lead, LP ... -
- Platform for Therapeutics
Theater 1Lucius Labs is a modern leader in cell culture aiming to lower costs and increase productivity through rapid innovation of cell culture media, buffers and analytical services. The company specializes ... -
- Regenerative Medicine
Theater 1LyGenesis is a clinical-stage biotechnology company developing a novel cell therapy platform leveraging patients' lymph nodes as bioreactors to grow functioning ectopic organs. LyGenesis' lead allogen ... -
- Inflammation
Theater 1Macrobiome Therapeutics (MBT) is pioneering a new class of therapeutics for inflammatory bowel disease (IBD) by harnessing millions of years of co-evolution between humans and hookworms, translating t ... -
- Other
Theater 4Merz Therapeutics is a specialty neurology biopharma focused on movement disorders, rare and orphan neurological diseases and chronic pain. Areas of highest interest include, Multiple Sclerosis, Parki ... -
- Platform for Therapeutics
Theater 1Model Medicines is an AI-first biotechnology company that uses a proprietary discovery engine to systematically identify conserved biological choke points and design precision therapeutics against the ... -
- Brain Health
Theater 4Montara Therapeutics is a San Francisco-based precision medicine neuroscience biotech developing safer, more efficacious therapies for patients with neurological diseases. Many promising brain drug ca ... -
- Immunology
Theater 3Mote Therapeutics is a next-generation RNA therapeutics company focused on overcoming one of the key limitations in nucleic acid medicine: targeted delivery beyond the liver. The company’s proprietary ... -
- Oncology
Theater 2Multimeric Biotherapeutics is developing the FortiVac vaccine technology to elicit powerful CD8+ T cell responses that are curative against tumor cells and microbial pathogens. The initial indication ... -
- AI and Digital Health
Theater 2Nabla Bio is a biomolecular AI company advancing JAM-2, a generative platform for de novo biologics design. Nabla continues to partner with leading biopharma companies through platform licensing and p ... -
- Multiple Therapeutics
Theater 1NanoSyrinx is a discovery-stage synthetic biology company specialising in the intracellular delivery of protein therapeutics using our nano-scale, cell-specific delivery technology - the Nanosyringe. ... -
- Brain Health
Theater 4Neurizon Therapeutics is a clinical-stage biotechnology company developing disease-modifying therapies that target the underlying pathology of neurodegenerative diseases, including Amyotrophic Lateral ... -
- Brain Health
Theater 4Newron (SIX: NWRN, XETRA: NP5) is a biopharmaceutical company focused on developing innovative therapies for diseases of the central and peripheral nervous system. Headquartered near Milan, Italy, wit ... -
- Brain Health
Theater 1Novastage is a world leader in transdermal patches that have superior safety, efficacy and compliance over oral and injectable forms. The founders have previously developed 14 patch products in the US ... -
- Metabolic Diseases
Theater 2Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our primary strategic focus is in obesity, diabetes and the related cardiometabolic diseases that impa ... -
- Cardiovascular
Theater 4Nuevocor is a biotechnology company developing novel therapies for genetic cardiomyopathies driven by aberrant mechanobiology, headquartered in Singapore with offices in the U.S. and Europe. In 2025, ... -
- Cell and Gene Therapy and Genome Editing
Theater 3Ocugen is a clinical-stage biotechnology company focused on developing and commercializing transformative gene therapies to address blindness diseases and other serious conditions. Leveraging a novel ... -
- AI and Digital Health
Theater 1ODDIFACT is an AI company dedicated to rare diseases. We have built a proprietary system that transforms off-label use of existing drugs into FDA-designated orphan drug programs structured, de-risked, ... -
- Oncology
Theater 4Onconic Therapeutics is a Korea-based research-driven biopharmaceutical company dedicated to developing innovative therapeutics in oncology and gastrointestinal diseases. Our mission is to deliver dif ... -
- Oncology
Theater 1Oncovita, a biotechnology company spin-off from the Pasteur Institute, developing MVdeltaC, an engineered measles-based immuno-virotherapy designed to expose solid tumors so the immune system can reco ... -
- Oncology
Theater 3Oxford BioTherapeutics is a clinical-stage oncology company, developing first-in-class antibody-based therapies to improve patient outcomes. Our proprietary, proteomic target discovery platform, OGAP® ... -
- Respiratory
Theater 4Paint Therapeutics is a privately held biotechnology company developing Peptide-Drug Conjugates using their PulmoPaint™ platform technology. The PulmoPaint™ platform utilizes a surfactant-derived pept ... -
- Other
Theater 1PAX Therapeutics, having completed IND-enabling studies, is on the cusp of clinical trials to demonstrate optimized tendon healing by the delivery of our growth factor vector which in preclinical stud ... -
- Tools/Drug Development Support Tech
Theater 3PEACCEL is a DeepTech company pioneering AI- and Quantum-driven peptide and protein design. Its proprietary innov’SAR platform integrates generative AI, ML, DL, and early Quantum machine learning to e ... -
- Orphan and Rare Disease
Theater 4Peptris is an AI powered preclinical drug discovery company with focus on rare diseases, inflammation, oncology, and Women's Health. Peptris has created AI models to generate novel molecules and predi ... -
- Oncology
Theater 3Phanes Therapeutics is a San Diego–based, clinical-stage immuno-oncology company advancing a wholly owned portfolio of differentiated antibody therapeutics for solid tumors. Phanes is conducting Phase ... -
- Orphan and Rare Disease
Theater 4Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening disease ... -
- Oncology
Theater 2Pinotbio, Inc. is a clinical stage biotech company developing novel ADC candidates based upon own proprietary platform technologies. Pinot-ADC, Pinotbio's own platform technologies, consist of a novel ... -
- Other
Theater 4PleoPharma, Inc. is a clinical stage development company in the neuropsych and addiction space focused on finding solutions for people suffering from cannabis addiction and other cannabis related heal ... -
- Oncology
Theater 2Precision NeuroMed (PNM) is a clinical-stage biotechnology company transforming the treatment of serious neurological diseases through precision brain delivery of biologic therapies, beginning with gl ... -
- Diagnostics and Personalized Medicine
Theater 1Proseek Bio is advancing a new class of companion diagnostics built on quantitative glycoproteomics—unlocking a critical layer of biology that DNA-based methods and conventional protein assays miss an ... -
- Tools/Drug Development Support Tech
Theater 3QYOBO is a live intelligence platform transforming how the pharmaceutical industry understands and manages global manufacturing networks. We replace fragmented spreadsheets and disconnected databases ... -
- Oncology
Theater 2Rakuten Medical is a clinical and commercial-stage biotech company advancing its investigational Alluminox™ platform, which is based on photoimmunotherapy. The company is developing the platform consi ... -
- Orphan and Rare Disease
Theater 4Reborna is a next-generation biotech pioneering RNA-targeted small molecule therapeutics to unlock disease mechanisms beyond the reach of conventional drug discovery. We are seeking strategic partners ... -
- Brain Health
Theater 4Recall Therapeutics is pioneering a breakthrough platform for memory restoration by discovering a new mechanism of action in Alzheimer’s disease, neurodegenerative diseases, oncology-related cachexia, ... -
- Platform for Therapeutics
Theater 1RecoRNA develops RNA‑targeted technologies to address diseases lacking effective treatments, with focus on genetic, neurologic, metabolic, and immuno‑oncology–addressable conditions. Our platform inte ... -
- Immunology
Theater 3Epigenetic reprogramming platform for antigen-specific immune-tolerance, 70M+ non-dilutive financing, founded by 2025 Nobel Laureate Shimon Sakaguchi: RegCell is developing a non-viral, non-gene-edite ... -
- Cell and Gene Therapy and Genome Editing
Theater 3REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Our gene therapy product candidates are designed to deliver genes t ... -
- Oncology
Theater 3Remedy Plan Therapeutics is a clinical-stage biotech company developing NAMPT inhibitors for patients with hematological malignancies and solid tumors. NAMPT is the rate-limiting enzyme responsible fo ... -
- Cardiovascular
Theater 4US-based Repair Biotechnologies develops the first potentially curative therapy for atherosclerotic cardiovascular disease, derived from a novel platform approach to undruggable aspects of cholesterol ... -
- Inflammation
Theater 1Pioneering Regenerative Macrophage Therapy in Inflammatory and Fibrotic Diseases UNMET MEDICAL NEED First indication in End Stage Liver Disease (ESLD), currently in the clinic TRANSFORMATIVE TREATMENT ... -
- Cell and Gene Therapy and Genome Editing
Theater 3RESTEM is a leading clinical-stage biotechnology company focused on developing off-the-shelf, next-generation cell therapies for autoimmune, inflammatory, and age-related diseases. Leveraging propriet ... -
- Ophthalmology
Theater 3RudaCure is a Korea-based clinical-stage biotechnology company focused on developing innovative therapies for incurable diseases with sensory based disorders and high unmet needs. RudaCure’s multi-ind ... -
- Oncology
Theater 3In drug development, the epitope matters. Current therapies targeting known epitopes can only help 20% of cancer patients. Sanavia Oncology Inc. is a Series B stage New York-based biotech company focu ... -
- Multiple Therapeutics
Theater 2We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our teams across the world strive to transform the practice of medici ... -
- Oncology
Theater 2Sapu is a private biotechnology company with more than 3 years in operation with over 50M funded. We are looking to be listed through an IPO late this year or early next year. The team is led by biote ... -
- Cell and Gene Therapy and Genome Editing
Theater 3Savanna Biotherapeutics is pioneering the world's first iPSC-derived microglia cell therapy platform. Our lead program, SB-101, replaces dysfunctional microglia in patients with ALSP, a fatal neurodeg ... -
- Oncology
Theater 3Sebastian BioPharma is a preclinical oncology company developing a next-generation Antibody–Oligonucleotide Conjugate (AOC) platform designed to overcome immunotherapy resistance in solid tumors. Our ... -
- Other
Theater 2Founded to serve health, Servier is a global group governed by a Foundation that aspires to have a meaningful social impact, both for patients and for a sustainable world. With its unique governance m ... -
- Inflammation
Theater 4Shaperon is a clinical-stage biotechnology company headquartered in Seoul, South Korea, developing therapies for immune and inflammatory diseases with high unmet need, across both small molecules and ... -
- Regenerative Medicine
Theater 1SMSbiotech is a clinical-stage regenerative medicine company developing a first-in-class Small Mobile Stem (SMS) cell therapy platform. Its lead COPD program has demonstrated early safety and encourag ... -
- Diagnostics and Personalized Medicine
Theater 1STARCO is building an AI-driven platform that transforms traditional histopathology by integrating spatial statistics, deep learning, and genetic profiling spatial transcriptomics to enhance cancer di ... -
- Multiple Therapeutics
Theater 4Stoked Bio is a translational biotechnology company established to develop new candidates for resistant infections and cancers identified by the world-leading AI models created and implemented in the ... -
- Dermatology
Theater 11. Global Presence: Operates in more than 100 countries 2. Diversified Business: Innovative medicines, branded generics, generics, and APIs 3. Emerging Markets: Operating at scale in more than 80 coun ... -
- Pain Management
Theater 2Sustained Therapeutics is developing a sustained-release drug delivery platform for localized delivery of drugs serving large unmet medical needs with significant market potential. Its lead product (S ... -
- Oncology
Theater 1Founded in 2018, the Swiss Rockets Group is an innovative umbrella company with a portfolio of several niche-leading biotech companies ranging from late-stage pre-clinical to Phase III. Swiss Rockets ... -
- Immunology
Theater 3SynAct Pharma AB is a clinical stage biotechnology company focused on developing novel resolution therapies for inflammatory diseases. Lead program, Resomelagon, Phase 2b in rheumatoid arthritis, is a ... -
- Oncology
Theater 2TaiRx, Inc. is a clinical-stage biotech company developing novel oncology therapies. Our lead asset, CVM-1118 (Foslinanib), is a first-in-class oral NCE targeting mitochondrial TRAP1 to induce apoptos ... -
- Infectious Disease and Vaccines
Theater 4TAXIS develops drugs to kill bacterial Superbugs. We are breaking the mold of antibiotic drug development, which has only yielded, over the past few decades, incremental innovations on old themes. Our ... -
- Cell and Gene Therapy and Genome Editing
Theater 3Tessera Therapeutics is pioneering Gene Writing™—a new genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source. Our mission is to cure disease ... -
- Immunology
Theater 3TG ImmunoPharma (TGI) is a clinical-stage biotech company to develop breakthrough therapeutics on immunotherapy, T cell engager and NK cell engager. It was founded in 2020 by Dr. Zhigang Tian, one of ... -
- Immunology
Theater 3Therorna Inc. is a clinical-stage biotechnology company pioneer in circular RNA (circRNA) filed. Built on its proprietary splint-free enzymatic circularization platform and targeted LNP delivery techn ... -
- Oncology
Theater 2Tidewave Bio is an early-stage biotechnology company developing a next-generation immunotherapy platform designed to overcome the fundamental limitations of cell therapy in solid tumors. The company’s ... -
- Pain Management
Theater 2 -
- Multiple Therapeutics
Theater 1Transpire Bio Inc. is an integrated US-based, revenue-generating, clinical-stage biopharmaceutical company headquartered in Sunrise, Florida. Transpire Bio harnesses its inhaled drug delivery expertis ... -
- Cardiovascular
Theater 1UniQuest is commercializing First‑in‑Class Troponin Modulator for the treatment of HFpEF. -
- Oncology
Theater 1VacV Biotherapeutics is headquartered in London and sources novel research and therapeutic concepts from Barts Cancer Institute, London, UK. We now have an R&D center at BioBay in Suzhou, China, and a ... -
- Brain Health
Theater 4Vibrant Therapeutics is a clinical stage company focused on neurological disease, oncology and immunology. We have recently secured additional $61M funding led by Pfizer Ventures. We have developed a ... -
- Brain Health
Theater 4Vincere Biosciences is redefining what’s possible by targeting one of the most fundamental drivers of mitochondrial dysfunction, which underlies several diseases including Parkinson’s disease (PD). Ra ... -
- Oncology
Theater 1ViroMissile is developing a new cornerstone of cancer treatments and turning immunologically cold tumors hot via our big breakthrough in effectively intravenously dosing an oncolytic virus (OV) as dem ... -
- Metabolic Diseases
Theater 3Vivani Medical, Inc. is a clinical stage biopharmaceutical company developing miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal™ technology, which is ... -
- Oncology
Theater 1VSPharmTech (VSPT) is a clinical-stage biotech company dedicated to its core mission: "Discovering the Better for a Paradigm Shift in Cancer Treatment." The company specializes in developing innovativ ... -
- Respiratory
Theater 4Xylyx Bio is developing first-in-class human lung grafts to significantly increase the number of lungs available for life-saving transplantation, increase hospital transplant volume and revenue, and r ... -
- Brain Health
Theater 4Zambon Biotech is focused in growing the specialty portfolio and pipeline of the Zambon group of companies by entering into partnerships, acquiring assets and supporting their clinical development up ... -
- Oncology
Theater 2Zymeworks is a global biotechnology company with a partner-driven R&D engine focused on advanced protein engineering, including next-generation antibody-drug conjugates (ADCs) and T cell–engaging ther ...
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}